Physician profile
Joyce Meng
NPI 1083649164
$388.93
in general payments reported to CMS, 2019-2025
9 companies · $68.37 in 2025
The $68.37 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $55.17 · 2021: $17.33 · 2024: $68.35 · 2025: $68.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $136.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $103.33 | 2019 | |
| Lantheus Medical Imaging, INC. | $74.67 | 2019-2021 | |
| Pfizer INC. | $48.87 | 2019-2020 | |
| Novo Nordisk INC | $35.87 | 2025 | Wegovy |
| Novartis Pharmaceuticals Corporation | $32.50 | 2025 | |
| Abbott Laboratories | $29.76 | 2024 | Jot Dx |
| Regeneron Healthcare Solutions, INC. | $25.34 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $20.27 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $18.32 | 2024 | Wainua |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Meng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.